Acquisitions (Tables)

3 Months Ended

Sep. 30, 2015

Acquisitions

Schedule of preliminary purchase price allocated to assets acquired and liabilities assumed

(In thousands)	Silarx Pharmaceuticals, Inc.
Cash	$	664
Accounts receivable, net of revenue-related reserves	4,396
Inventories	2,705
Property, plant and equipment	7,247
Silarx product rights	10,000
Silarx in-process research and development	18,000
Goodwill	141
Other current assets	9
Other assets	348
Total assets acquired	43,510
Accounts payable	(711		)
Income taxes payable	(273		)
Total fair value of acquisition	$	42,526